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Abstract
The aim of the research. Development and implementation of new methods for pre-operative staging of advanced ovarian, gas-
tric and colorectal cancer to improve patient selection for cytoreductive surgery and increase its radicality.
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Materials and methods. Data from 120 patients with advanced ovarian cancer, 28 with advanced gastric cancer and 119 with 
advanced colorectal cancer were analyzed. Preoperative detection of the incidence of peritoneal carcinoma and the possibility of sur-
gery in radical or cytoreductive volume performed by CT with intravenous contrast (72 patients with ovarian cancer, 17 patients with 
gastric cancer, and 69 patients with colorectal cancer), and MR T1 and T2, contrast-enhanced T1, and diffuse-weighted sequences 
(48 patients with ovarian cancer, 11 patients with gastric cancer, and 50 patients with colorectal cancer). Subsequently, preoperative and 
intraoperative assessment of the prevalence of the tumour process with peritoneal carcinoma index (PCI) by Sugarbaker was performed.
Results. A statistically significant increase in the informativeness of the preoperative assessment of the incidence of tumour 
process in peritoneum and the presence of distant metastases using DWI/MRI compared with CT with intravenous contrast was de-
termined. Patients from all groups were categorized according to the completeness index of cytoreduction achieved by preoperative 
staging and patient selection using DWI/MRI and CT. The use of DWI/MRI allowed to significantly reduce the number of suboptimal 
and non-optimal cytoreductive interventions.
Conclusions. DWI/MRI has made it possible to significantly improve the preoperative incidence of advanced ovarian, gastric, 
and colorectal cancer compared to CT, predict the radicality of future surgery, and detect inoperable cases.
Keywords: magnetic resonance imaging with diffuse-weighted imaging (DWI/MRI), computed tomography (CT), peritoneal 
carcinoma index (PCI), cytoreductive surgery.
DOI: 10.21303/2504-5679.2019.001071
1. Introduction
According to the National cancer registry of Ukraine, in 2017, with ovarian, gastric and col-
orectal stage III cancer patients were diagnosed 43.4 %, 22.3 %, and 23.5 % of patients, respective-
ly; stage IV – 15.5 %, 37.8 % and 22.9 % of patients, respectively. Surgical and chemotherapeutic 
treatment are the main methods of control of these diseases and the radicality of the surgery largely 
determines the degree of response to the chemotherapy treatment and the overall and relapse-free 
survival of patients [1, 2]. At present, the main method of diagnosis of locally advanced processes 
in the abdomen is computed tomography with intravenous contrast (CT) [3]. Correct preoperative 
staging with the help of peritoneal index of carcinomatosis proposed by P. Shugarbaker allows to 
determine the order of combinated treatment, the expediency of surgical treatment and its probable 
volume and radicality [4, 5]. However, according to the literature, CT does not allow to achieve a 
significant correlation in the estimation of the extent of abdominal tumour and the possibility of its 
complete removal. Magnetic resonance imaging using diffuse-weighted imaging (DWI/MRI) can 
be a complement or alternative to CT in these cases [6, 7].
The aim of the research – development and implementation of new methods of pre-oper-
ative staging of advanced ovarian, gastric and colorectal cancer to improve patient selection for 
cytoreductive surgery and increase its radicality.
2. Materials and methods
Clinical cases of 120 patients with advanced ovarian cancer (stage III and IV with fi-
nal diagnosis), 28 with advanced gastric cancer (stage IV with final diagnosis) and 119 with 
advanced colorectal cancer (stage IV with final diagnosis) were considered. Preoperative de-
tection of the incidence of peritoneal carcinoma and the possibility of surgery in radical or 
cytoreductive volume performed by CT with intravenous contrast (72 patients with ovarian 
cancer, 17 patients with gastric cancer, and 69 patients with colorectal cancer), and MR T1 and 
T2, contrast-enhanced T1, and diffuse-weighted sequences (48 patients with ovarian cancer, 
11 patients with gastric cancer, and 50 patients with colorectal cancer). Subsequently, preoper-
ative and intraoperative assessment of the incidence of tumour process by the peritoneal car-
cinomatosis index (PCI) by Sugarbaker was performed. Preoperative PCI restaging by both 
methods was performed by two radiologists independently including differences in statistical 
analysis to generate generalized values and compared with intraoperative evaluation. Patients 
were categorized by us according to the value of intraoperative PCI into three groups (PCI<10, 
10<PCI<20, PCI>20), due to the complexity of achieving optimal cytoreduction in these cases 
of the prevalence of tumour process and the index of completeness of cytoreduction, which 
illustrated radicality intervention [8, 9].
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The research was carried out within the framework of the scientific work of the Depart-
ment of Surgery No. 4 with the oncology course of the Odessa National Medical University. 
Compliance with the WMA Declaration of Helsinki – Ethical Principles for Medical Research 
Involving Human Subjects, 2013 (minutes of the meeting of the Committee on Bioethics of the 
Odessa National Medical University No. 167A dated September 12, 2019) was determined. All 
study participants were informed and agreed to the processing of their clinical data and to par-
ticipate in the research process.
Statistical analysis of the obtained data was performed using GNU PSPP version 1.2.0 using 
the non-parametric Friedmann χ2 test.
3. Results
In patients with ovarian cancer, DWI/MRI better revealed distant metastases in 8 out of 
9 patients, compared to 2 in 15 with CT. In the category of patients with PCI<10, similar to intraop-
erative staging with DWI / MRI was obtained in 22 of 23 patients (95.7 %), versus 15 of 43 (34.9 %) 
with CT (p<0.05). In the category of patients with 10<PCI<20 DWI/MRI – 13 out of 15 (86.7 %), 
CT 5 out of 17 (29.4 %) (p<0.05). In the category of patients with PCI>20 DWI / MRI – 9 out of 10 
(90 %), CT 3 out of 12 (25 %) (p <0.05) (Fig. 1).
Fig. 1. The proportion of patients with similar preoperative and intraoperative staging with  
DWI/MRI and CT in ovarian cancer.
In patients with gastric cancer DWI/MRI, distant metastases were detected in 4 of 5 patients, 
compared with 6 of 11 in CT. In the category of patients with PCI<10, similar staging using DWI/MRI 
was obtained in 3 of 3 patients (100 %), versus 2 of 5 (40 %) at CT (p<0.05). In the category of patients 
with 10<PCI<20 DWI/MRI – 3 out of 4 (75 %), CT 3 out of 7 (42.8 %) (p<0.05). In the category of 
patients with PCI>20 DWI / MRI – 4 out of 4 (100 %), CT 3 out of 5 (60 %) (p <0.05) (Fig. 2).
 
Fig 2. The proportion of patients with similar preoperative and intraoperative staging with  
DWI/MRI and CT in gastric cancer.
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In patients with colorectal cancer, DWI/MRI better revealed distant metastases in 7 out of 
10 patients, compared with 3 in 10 with CT. In the category of patients with PCI<10, similar stag-
ing using DWI/MRI was obtained in 15 of 17 patients (88.2 %), versus 12 of 21 (57.1 %) with CT 
(p<0.05). In the category of patients with 10<PCI<20 DWI/MRI – 18 out of 20 (90 %), CT 10 out 
of 32 (31.2 %) (p<0.05). In the category of patients with PCI>20 DWI/MRI – 11 out of 13 (84.6 %), 
CT 5 out of 16 (31.2 %) (p<0.05) (Fig. 3). 
Fig. 3. The proportion of patients with similar preoperative and intraoperative staging with  
DWI/MRI and CT in colorectal cancer
Patients from all groups were categorized according to the completeness of cytoreduction 
index achieved through preoperative staging and patient selection using DWI/MRI and CT. Op-
timal CC-0 cytoreduction (no macroscopic residual tumor) and radical surgery were achieved in 
53 % of patients staged with DWI/MRI and 46 % staged with CT (p<0.05). Suboptimal cytore-
duction of CC-1 (residual tumor less than 2.5 mm) were achieved in 37 % of patients staged with 
DWI/MRI and 29 % staged with CT (p<0.05). Non-optimal CC-2-3 cytoreduction (residual lesions 
greater than 2.5 mm) were achieved in 10 % of patients staged with DWI/MRI and 25 % staged 
with CT (p<0.05) (Fig. 4).
Fig. 4. The proportion of patients among whom optimal (CC-0), suboptimal (CC-1) and non-
optimal (CC-2-3) cytoreduction was achieved with preoperative staging using DWI/MRI and CT
4. Discussion of the results
Compared with other studies of the efficacy and relative efficacy of DWI/MRI in colorectal 
cancer [10, 11], ovarian cancer [12, 13] and stomach cancer [14, 15], similar results are obtained, 
illustrating the reproducibility of the experiment regardless of the treatment center used, study 
protocols, and subjective evaluation of PCI ranking results.
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The obtained results allow us to recommend DWI/MRI for pre-operative staging at all three 
investigated localizations of the tumour process. Comparing the results of staging with DWI/MRI 
revealed a significant number of advantages over CT. First, DWI/MRI revealed a greater number 
of distant metastases, which in the future will allow in these cases to correctly select the stage 
of complex cancer treatment in patients requiring neoadjuvant chemotherapy before primary cy-
toreductive surgery [16]. Second, DWI/MRI in many cases of ovarian cancer revealed lesions of 
visually and palpatory unchanged regional lymph nodes. This fact will, in the long run, reduce the 
number of routine lymph node dissections in visually unaffected lymph nodes without reducing 
the radicalism of surgery and worsening the oncological results in these patients [17]. A similar 
situation arises when addressing the issue of extending standard volumes of lymph node dissection 
in gastric and colorectal cancer [18, 19]. Third, in the analysis of the local spread of the oncological 
process by the DWI/MRI method, the significant correlation of preoperative and intraoperative 
PCI allowed to predict better the future surgery, which made it possible to increase the radicality 
of the interventions. Also, CT sensitivity was limited by the size of tumors less than 5 mm and lo-
calization in certain anatomical areas (e. g. Omental foramen, lesser omentum, left hemidiaphragm 
and serous surface of the small intestine). However, a greater sensitivity of imaging with DWI/MRI 
was obtained in the presence of infiltrative and miliary carcinomatosis, which in many cases re-
mained unnoticed in CT diagnosis, which dramatically changed the stage and volume of the opera-
tion. Better sensitivity of DWI/MRI, even at high PCI values, is also important, as it is in this group 
of patients that cases of inability to perform the optimal amount of cytoreductive intervention have 
been observed, which significantly impaired the predicted cancer outcomes. Despite these advan-
tages, the relatively high cost, long study time, and the presence of absolute contraindications put 
the MRI on the second line for the detection and evaluation of tumors of the abdominal cavity.
Study limitations. This study was monocentric, nonrandomized and retrospective. The 
main limitation of the study is the retrospective recruitment of groups of patients who underwent 
surgery after pre-operative staging, and therefore did not include patients declared inoperable and 
patients with potentially suboptimal cytoreduction who were advised with neoadjuvant chemo-
therapy. The investigated data used the restaging of the pre-operative evaluation of the prevalence 
of the tumor process, conducted by two independent radiologists already at the time of the ret-
rospective study, which in some cases differed from the conclusions obtained by patients during 
pre-operative diagnosis.
Prospects for further research. In the future, it is planned to compare the results obtained 
with the results of preoperative staging of widespread oncological processes by means of positron 
emission computed tomography and positron emission magnetic resonance imaging, which, like 
DWI/MRI, supplement information on molecular level disorders to the clear visualization of tis-
sues and organs achieved by the main research [20].
5. Conclusions
DWI/MRI significantly improves the pre-operative staging of advanced ovarian, gastric 
and colorectal cancer compared to CT, predicts the radicality of future surgery and identifies in-
operable cases. DWI/MRI significantly outperforms CT in visualization of metastatic lesions of 
the peritoneum, abdominal organs, and extraperitoneal space for ovarian, gastric, and colorectal 
cancer. DWI/MRI can be used in planning of the treatment of these diseases, reducing the number 
of unnecessary exploratory laparotomies and suboptimal cytoreductive interventions.
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Abstract
The article analyzes the strengths, weaknesses, potential opportunities and threats in the process of forming and making appro-
priate management decisions to integrate health facilities into united territorial communities (UTC) infrastructure, or other options, in 
the process of decentralization. The basic package of new legislative and regulatory documents has been worked out, which envisages 
radical changes and systemic reforms, decentralization of power - transfer from the executive bodies to local self-government bodies of 
a considerable part of powers, resources and responsibilities. A number of reform changes have been identified, which may lead to the 
expected institutional, organizational and structural-functional changes of the existing public health management system in Ukraine 
and changes in the individual functional characteristics of the entities of this system. The differences between medical reforms in terms 
of administrative reform, the role of UTC in this process, in relation to a number of other European countries are considered. On this 
basis, possible options for the development of events in the context of territorial governance of these processes in the system of health 
in Ukraine have been proposed. In order to continue scientific research in this direction, the next stage of the evolution of the formation 
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